These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia. Toft-Petersen M; Stidsholt Roug A; Plesner T; Ebbesen L; Brown GD; Nederby L Cytometry B Clin Cytom; 2018 May; 94(3):520-526. PubMed ID: 28718199 [TBL] [Abstract][Full Text] [Related]
10. Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications. Gagné V; Marois L; Levesque JM; Galarneau H; Lahoud MH; Caminschi I; Naccache PH; Tessier P; Fernandes MJ Arthritis Res Ther; 2013 Jul; 15(4):R73. PubMed ID: 23837669 [TBL] [Abstract][Full Text] [Related]
11. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways. Futosi K; Fodor S; Mócsai A Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Futosi K; Fodor S; Mócsai A Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464 [TBL] [Abstract][Full Text] [Related]
13. Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease. Favier B Immunol Rev; 2016 Sep; 273(1):140-55. PubMed ID: 27558333 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the complex of CLEC12A and an antibody that interferes with binding of diverse ligands. Mori S; Nagae M; Yamasaki S Int Immunol; 2024 Apr; 36(6):279-290. PubMed ID: 38386511 [TBL] [Abstract][Full Text] [Related]
15. Clec12a: quieting the dead. Yamasaki S Immunity; 2014 Mar; 40(3):309-11. PubMed ID: 24656042 [TBL] [Abstract][Full Text] [Related]
16. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Kanazawa N; Tashiro K; Miyachi Y Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152 [TBL] [Abstract][Full Text] [Related]
17. The Fusion of Dhungel BP; Monteuuis G; Giardina C; Tabar MS; Feng Y; Metierre C; Ho S; Nagarajah R; Fontaine ARM; Shah JS; Gokal D; Bailey CG; Schmitz U; Rasko JEJ Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830054 [TBL] [Abstract][Full Text] [Related]
18. Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome. Toft-Petersen M; Nederby L; Kjeldsen E; Kerndrup GB; Brown GD; Hokland P; Stidsholt Roug A Br J Haematol; 2016 Nov; 175(3):393-401. PubMed ID: 27612176 [TBL] [Abstract][Full Text] [Related]
19. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. Sagar D; Singh NP; Ginwala R; Huang X; Philip R; Nagarkatti M; Nagarkatti P; Neumann K; Ruland J; Andrews AM; Ramirez SH; Khan ZK; Jain P Sci Rep; 2017 Jun; 7(1):2707. PubMed ID: 28578388 [TBL] [Abstract][Full Text] [Related]
20. C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity. Drouin M; Saenz J; Chiffoleau E Front Immunol; 2020; 11():251. PubMed ID: 32133013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]